Robert H. Hall, Ph.D.

Enteric and Hepatic Diseases Branch 11912 Hall Shop Road

National Institute for Allergy and Infectious Diseases Clarksville

National Institutes of Health MD 21029

Bethesda abqkmr@r.postjobfree.com

MD 20892-6603 301-***-****

Current Assignment

GS-0403 Microbiologist -- Program Officer in Enteric and Hepatic Diseases, NIAID, NIH

Duties

1> Manage research and product development program in:

A:> -- Cholera, Vibrio, and Aeromonas

B:> -- Enteric and hepatic disease diagnostics

2> Responsible for assigned and related scientific fields; advise senior leaders as & when

required; communicate research agenda and resources to scientific community; respond

to new priorities with new initiatives for RFAs, cooperative agreements, and contracts.

3> Represent Program to Branch, Division, & Institute leadership

4> U.S. Secretariat: US-Japan Cooperative Medical Sciences Program Panel on Cholera

and Other Bacterial Enteric Infections

Recent Accomplishments

> Proposed, authored, and co-authored RFA funding opportunity announcements, instructed

reviewers, participated in funding plans

> Contracting Officer s Technical Representative on Contracts and Task Orders

> Represented EHDB, DMID, NIAID, and NIH in presentations & on committees: research

resources & program, cholera, infectious disease & climate change, and risk assessment

> 2008, 2009, 2010: Excellent ratings with Performance Bonus

Educational History

University of Aberdeen, Scotland, U.K. 1976-80: B.Sc. (Honors) in Microbiology

University College, University of London, England, U.K. 1980-84: Ph.D. in Microbiology

Selected Additional Training

1991-2 FAES: Principles of Management for Scientists & Administrators (Grade A); FDA: Basic

Project Officer (100%), 1992 FAES: Biotechnology Law & Policy (Grade A), Georgetown Univ.

Law Center: Food & Drug Law, FAES: Recombinant DNA Methodology, 1993 Univ. MD: Current

Issues in the Management of Technology and Innovation (Grade A), FDA: Basic Food and Drug

Law, 1996 FDA: Field Training, 1997 FDA: Regulatory Microbiology Mentoring Program, 2002

NIH: Basic Project Officer (100%), 2006 Extramural Scientific Administrator Seminars, 2010

FAES TRAC31: Vaccines: Development and Evaluation of Efficacy, 2010 International Vaccine

Institute Advanced Course on Vaccinology in Asia-Pacific Regions, 2011 Federal

Appropriations Law, 2011 Good Clinical Practice

Employment History & Professional Experience

1983-85 Postdoctoral Research Fellow of the Wellcome Trust.

Department of Medical Microbiology, London School of Hygiene and Tropical

Medicine, London, England, U.K.

1985-88 Postdoctoral Fellow of the Swiss Serum and Vaccine Inst. & NIAID

Center for Vaccine Development (CVD), Univ. MD Sch. of Med, Baltimore

1988-90 Instructor of Medicine, CVD, Univ. MD Sch. of Med, Baltimore.

1990-91 Research Assistant Professor (Medicine and Biological Chemistry), CVD, & Dept

of Biological Chemistry, Univ. MD Sch. of Med, Baltimore

1991-97 Senior Staff Fellow, Food and Drug Administration, Center for Food Safety &

Applied Nutrition, Division of Virulence Assessment, Washington DC

1997 Grade Increase to GS 14 - 0403 Microbiologist in FDA/CFSAN

2001 Ad hoc Acting Branch Chief, Virulence Mechanisms Branch, FDA/CFSAN

2002-present Program Officer, Enteric & Hepatic Diseases Branch, Division of Microbiology

and Infectious Disease, NIAID, NIH

2003-4 Special Member of the Graduate Faculty in Food Science, Univ MD College Park

2002-present Faculty Professor, Foundation for the Advanced Education in the Sciences

2003-present Adjunct Lecturer in College of Life Sciences, Univ. MD College Park

Selected Honors & Awards

1995 FDA Group Recognition Award " . as a member of the V. cholerae research team for

original research of novel pathogen V. cholerae serogroup O139, which provided a clear

evaluative perspective of this organism."

1997 FDA Group Recognition Award " . as a member of Salmonella enteritidis Field

Sampling Force for exceptional contributions . through investigations of egg

production facilities implicated in foodborne Salmonella enteritidis outbreaks."

1997 FDA Commissioner's Special Citation " .. for outstanding performance in developing a

program [FSI] to ensure the safety of the American food supply."

1998 FDA/CFSAN Special Accomplishment Award presented to Robert H. Hall, Ph.D. for ..

in traceback investigations on Salmonella enteritidis associated with shell eggs.

1999 FDA/CFSAN award for outstanding leadership to numerous JIFSAN students

persistence in applying for grants . and technology transfer

2000 Special Accomplishment Award for dedication & initiative in task force efforts

2002 FDA/CFSAN Leadership Award for outstanding leadership to numerous JIFSAN

students...

2003 NIAID Special Act or Service Award for organizing a BoNT diagnostics workshop

2004 NIAID Special Act or Service Award for increasing research on under-emphasized

diarrheagenic organisms

2005 NIAID Special Act or Service Award for: promoting investigator involvement and access

to DMID s genomics activities and leading the Institute s efforts to draft the health section

of the Strategic Plan for the U.S. Interagency Working Group on Earth Observations

2005 Quality Step Increase

2008 FDA Leveraging/Collaboration Award to members of InterAgency Risk Assessment

Consortium: For interagency collaboration to provide public forums for discussing risk

assessment issues related to keeping food and water safe for public consumption.

2009 NIAID Merit Award for Outstanding performance and commitment to the US-Japan

Cooperative Medical Sciences Program

2008, 2009, 2010: Excellent Ratings with Performance Bonus

2011 NIAID Merit Award In recognition of services performed as acting branch chiefs of the

Enteric and Hepatic Diseases Branch of DMID

Competitive Research Funding

R. Hall, et al., PI (2000) Optimizing Strand Displacement Amplification for Pathogen Detection

and Quantification in the Field. Food Safety Initiative Intramural Competitive Funding to Support

Priority CFSAN Research: 2 Year Funding including Post-Doc ($~120,000)

R. Hall, et al., PI (2001) Nanotechnology biosensor to identify microbial contamination of foods,

biologics, and medical devices. (Funding rate approx. 5 of 97 submissions) FDA -Office of

Science Coordination and Communication Competitive Funding ($40,000)

R. Hall, et al., PI (2002) Application of biospecific nanoelectromechanical cantilevers to the

exposure assessment of microbiological hazards. (Funding rate approx. 5 of 67 submissions)

FDA-Office of Science Coordination and Communication Competitive Funding ($54,000)

Selected Professional Activities

1993 Position Paper on Critical Scientific Issue: "Comments To The Record". FDA

Response to the Emergence of V. cholerae O139. 29th Joint Conference on

Cholera and Related Diarrheal Diseases. U.S.-Japan Cooperative Medical

Sciences Program. Asilomar CA. Dec. 5-9

1997-2002 Credentialed U.S. Federal Agent acting under Inspectional Warrant and

Custodial Rules of Evidence in the FDA Compliance Program on Salmonella

food-borne disease trace-back. Drag-swabbed and sampled egg-producing

facilities in MD, SC, & PA

1997 FDA/CFSAN Member of team drafting the Food Safety Initiative document for the

White House (sections on emerging pathogens and detection methods)

1996 FDA representative to CODEX Wastewater Recycling Subcommittee of the Food

Hygiene Committee tasked with preparing Policy Briefing Paper for the Food

Hygiene Committee

1997 FDA representative to CODEX Food Hygiene Committee tasked with preparing

Policy Briefing Paper on U.S. position paper on hygienic reuse of wastewater in

food processing plants

1998 Selected for FDA/CFSAN Microbiology Mentoring Program in Regulatory

Microbiology

1998 FDA/CFSAN rep. for food-borne risks of bovine spongiform encephalopathy

1998 FDA representative to observe AOAC International Food Laboratory Working

Group (FLAWG) Microbiology subcommittee developing accreditation criteria

1999 FDA/CFSAN representative to the FDA Science Forum. Organizer of Food

Safety Initiative session

2000 FDA/CFSAN/ORA Joint Committee SubGroup on the Science Base Alternate

CFSAN Co-Chair

2000 FDA/CFSAN Out-of-the-Box Research Management Review. Team member

2002 Reassigned to EHDB/NIAID. Program has included hepatic & enteric diagnostics,

cholera, Vibrio, Aeromonas, Helicobacter, Listeria, Clostridia, and Campylobacter

2002-present NIH representative to the multi-agency Risk Assessment Consortium

2004 Microbiology contributing representative to International Group on Earth

Observations. White House 10-yr Plan for a System of Systems

2004 Co-organizer of Enteric Vaccines for Pediatric Use workshop. 50 expert

participants strategizing on future direction to be taken to expedite the research,

development and deployment of vaccines protecting against diarrhea

2005-present Contracting Officer s Technical Representative (COTR)

2004-present Lead organizer of US-Japan Cholera & Other Bacterial Enteric Infections Panel

Meeting and Conference: Bethesda 2003; Boston 2005; Austin 2007, San Diego

2009; Kolkata 2011. Organizing Committee: 2004, 06, 08, 10

Received funding from NIAID to conduct 1st Training Mission in Cholera

2008

Collaborative Research and Case Management, Kolkata

2nd NIAID Representative to NIH Working Group on Climate Change and Health

2009

2011 Position Paper on Critical Scientific Issue: Cholera: Mechanism for Control and

Prevention for WHO 64th World Health Assembly, May 16-24, 2011

2011 Assigned to lead Enteric & Hepatic Diseases initiative development effort to

provide Branch recommendations for future research under 2013 initiatives

2008 -present Reviewed for Vaccine, PLoS Neglected Tropical Diseases, Applied Microbiology

and Biotechnology

2010 -present Editorial Board Member: The Botulinum Journal

Technology Transfer Activity: Invention Disclosure Reports

1. Hall, RH & V Sathyamoorthy (1993) Pure thermostable hemolysin of Vibrio parahaemolyticus

2. Hall, RH & S.P. Keasler (1993) Detection and classification of Vibrio cholerae using the

multiplex polymerase chain reaction

3. Hall, RH & Jian-Guo Xu (1994) A new and distinctive DNA sequence of E. coli O157:H7 and

its use for the rapid, sensitive and specific detection of O157:H7 and other

enterohemorrhagic E. coli

4. Craighead, HG & RH Hall (2000) Biological Detection Systems Based on Providing

Biomarker Specificity to Miniaturized, Resonant, Mass-Measuring Instruments

Patents Issued

1>--Hall, Robert H. & Jian-Guo Xu: A new and distinctive DNA sequence of E. coli O157:H7 and

its use for the rapid, sensitive and specific detection of O157:H7 and other

enterohemorrhagic E. coli. Patent Number 5,475,098 Filed June 14, 1994, Issued Dec.

12, 1995. Successfully licensed

2>--Hall, Robert H. & Jian-Guo Xu: Rapid, Sensitive, and Specific Detection of O157:H7 and

Other Enterohemorrhagic E. coli. Patent Number 5,756,293 Filed Sept. 11, 1995, Issued

May 26, 1998. Successfully licensed

3>--Craighead, H.G., B. Ilic, D. Czaplewski, & R.H. Hall: High Sensitivity Mechanical Resonant

Biosensor. U.S. Patent Filed Nov. 14, 2000 Awarded as US Patent 7,148,017B1

4>--Ilic, B., D. Czaplewski, R.H. Hall, & H.G. Craighead: High Sensitivity Mechanical Resonant

Sensor Awarded as US Patent 7,691,583(B3) April 6, 2010

Licensing Activities -- Federal Register, October 11, 1995, Vol. 60, No. 196, Page 52919

Memberships & Offices Held (current or lapsed)

Amer. Assoc. for the Adv. of the Sciences, Inst. of Biology, Soc. for Gen. Microbiol, Royal Soc.

for Trop. Med. and Hygiene, Biochem. Soc, Amer. Soc. for Microbiol, Washington DC Branch of

the Amer. Soc. for Microbiol numerous posts over several years including Editor of

MicroscOOps Newsletter, Science Fair judge, committee memberships & chairs, and President

of DC-ASM (1998-1999). Mycological Soc of Washington DC.

Selected Organizing Committees:

2002-present: US-Japan CMSP Conferences on Cholera & Other Bacterial Enteric Infections

2003: 8th Internat. Conf. on Emerging Infectious Disease of the Pacific Rim, Dhaka, Bangladesh

2005 - 2010: Food & Waterborne Diseases: Annual Contractor Conference & Review

2006 - present: International Research in Infectious Diseases, NIAID Investigators Annual

Conference.

th

2009: 13 Internat. Conf. on Emerging Infectious Disease of the Pacific Rim. Kolkata, India

2010: Middle East-North Africa International Conf. on Waterborne Pathogens. Nicosia, Cyprus

2009 - present: Vaccines for Enteric Diseases

2011: Therapeutics for Acute Diarrheas (trans-NIH workshop; Bethesda, MD. Oct. 2011)

2009 - present: Vibrio2011 (internat. conf. Sept 2011, Univ. de Santiago de Compostela, Spain)

2011: Vaccines: Strategic Enterprise and Leadership NIAID/NIH

2010 present: Cholera Control & Prevention Committee (Global Strategy Committee)

Selected Special Invitations:

1992: Gordon Conference on Toxins and Microbial Pathogenesis, Colby-Sawyer College, NH

1993: Invited Presentation: "Vibrio cholerae non-O1 associated with cholera gravis genetically

and physiologically resembles O1 El Tor cholera strains" US-Japan 29th Conf. on

Cholera and Related Diarrheal Diseases. Asilomar CA

1994 Invited Lecture: "Detecting and Isolating the Escherichia coli O157:H7 Organism:

Recent Developments" American Gastroenterological Association Consensus Meeting,

Washington DC: "E. coli O157:H7 An Emerging Public Health Crisis"

1994: Invited Lecture: "Vibrio: New Techniques for Epidemiology" Food and Drug

Administration: Advances in Food Microbiology. Bothell, WA

1994: Chaired Session: US-Japan 30th Conf. on Cholera and Related Diarrheal Diseases,

Fukuoka City, Japan

1994: Invited Presentation: "Rapid Identification of Enterohemorrhagic Escherichia coli by

Targeting Unique hlyAB Sequences" US-Japan 30th Conf. on Cholera and Related

Diarrheal Diseases. Fukuoka City, Japan

1994: Invited Lecture: "Enterohemorrhagic E. coli in the USA." Dept of Microbiology, Inst. for

Epidemiology and Microbiology, Chinese Acad. for Preventive Medicine, Beijing, PRC

1998: Invited Lecture: Biotechnology Patenting and You American Society for Microbiology,

Washington DC Branch. Sheraton Columbia, MD

2000: Invited Lecture: Colloquium Department of Nutrition and Food Science, Univ. of MD

2002: Gordon Conference on Nanostructure Fabrication, Tilton College, New Hampshire

2003: Session Keynote speaker: The Knowledge Foundation Biodetection 2003

2006 - present: International Research in Infectious Diseases, NIAID Investigators Annual

Conference co-organizer & moderator

2009: Invited Keynote speaker: International Symposium on Fifty Years of Discovery of

Cholera Toxin: A Tribute to SN De Kolkata, India.

2010: Invited Speaker: Dept of Microbiology and Immunology, Univ. of Michigan Med. School

2010: Presented enteric disease program to various visiting delegations from North Africa

2010: Presented enteric & hepatic disease research programs to delegation from Pakistan

2010: Invited Speaker: Environmental Health Information Partnership, National Library of

Medicine. Bethesda, MD.

2010: Invited Speaker: US-Japan Biodefense Program Bethesda, MD

2010: Invited Participant: Enteric Fever Diagnostics London UK

2010: Invited Speaker: Okayama University, Japan

2011: Speaker & Co-organizer: International Conf. on Emerging Food and Waterborne

Diseases of the Middle East North Africa Region. Nicosia, Cyprus

2011: Keynote Speaker & Co-organizer: Vaccines for Enteric Diseases, Cannes, France

2011: Invited speaker: ICDDR,B, Dhaka, Bangladesh

Mentoring Activities

1991-2002: Laboratory trained, mentored & supervised (at least 1 semester) 1 high school

student, 7 Univ. MD) students, 1 HACU student, one visiting professor, one

detailee, & one postdoc. On Ph.D Advisory Committee for one Graduate Student

in Univ. MD, Dept. of Nutrition and Food Science

2005-2009: Mentored new staff in Enteric & Hepatic Diseases Branch, DMID/NIAID

Teaching Experience

*Faculty Professor: 2003 - present; FAES-MICR 418: Emerging Infectious Diseases: A Threat to

Global Health 3 credit graduate-level class in the Foundation for Advance Education in the

Sciences: the NIH Graduate School Ranging from 27 40 students, ~30% with Ph.D. degrees

*Adjunct Lecturer: 2003 - present; University of Maryland, College Park, College of Life

Sciences. Masters of Life Sciences web-based e-learning program

LfSc 609G Emerging Infectious Diseases - 3 credits (up to 30 students per class)

LfSc 609D Microbiology - 3 credits (up to 30 students per class)

LfSc 608: Special Topics in Life Sciences 1-4 credits mentored 40 capstone theses

Total graduate students taught 2003-present: ~650

Refereed Publications

1. Hall, RH (l984) Motility and taxis in photosynthetic bacteria. Thesis: University College,

University of London, U.K.

2. Levine, MM, JB Kaper, DA Herrington, G Losonsky, JG Morris, ML Clements, RE Black,

BD Tall, RH Hall (1988) Deletion mutants of Vibrio cholerae O1 prepared by

recombinant techniques: insights on pathogenesis and immunity. Infect Immun 56:161-7

3. Hall, RH, PA Vial, JB Kaper, JJ Mekalanos, MM Levine (1988) Morphological studies

on fimbriae expressed by Vibrio cholerae O1. Microb Path 4:257-65

4. Herrington, DA, RH Hall, G Losonsky, JJ Mekalanos, RK Taylor, MM Levine (1988)

Toxin, toxin co-regulated pili and the toxR regulon are essential for Vibrio cholerae

pathogenesis in humans. J Exp Med 168:1487-92

5. Hall, RH, D Maneval, JH Collins, JL Theibert, MM Levine (1989) Purification and

analysis of colonization factor antigen I, coli surface antigen 1 and coli surface antigen 3

fimbriae from enterotoxinogenic Escherichia coli. J Bacteriol 171:6372-4

6. Sharma, DP, C Thomas, RH Hall, MM Levine, SR Attridge (1989) Significance of

toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse

model. Vaccine 7:451-6

7. Hall, RH, BS Drasar (1990) Vibrio cholerae HlyA hemolysin is processed by

proteolysis. Infect Immun 58:3375-9

8. Hall, RH, GA Losonsky, APD Silveira, RK Taylor, JJ Mekalanos, ND Witham, MM

Levine (1991) Immunogenicity of Vibrio cholerae O1 toxin coregulated pili in

experimental and clinical cholera. Infect Immun 59:2508-12

9. Franco, A, C Gonzalez, OS Levine, R Lagos, RH Hall, SL Hoffman, MA Moechter, E

Gotuzzo, MM Levine, DM Hone, JG Morris (1992) Further considerations on the clonal

nature of Salmonella typhi: Evaluation of molecular and clinical characteristics of strains

from Indonesia and Peru. J Clin Microbiol 30:2187-90

10. Nataro, JP, D Yikang, JA Giron, SJ Savarino, R Hall, P Guerry, MM Levine (1993)

Aggregative adherence fimbriae I expression in enteroaggregative Escherichia coli

requires two plasmid regions. Infect Immun 61:1126-31

11. Huntley, JS, AC Hall, V Sathyamoorthy, RH Hall (1993) Cation flux studies of the

lesion induced in human erythrocyte membranes by the thermostable direct hemolysis

of Vibrio parahaemolyticus. Infect Immun 61:4326-32

12. Keasler, SP, RH Hall (1993) Detecting and biotyping Vibrio cholerae O1 with multiplex

polymerase chain reaction. Lancet (letter) 341:1661

13. Hall, RH, FM Khambaty, M Kothary, SP Keasler (1993) Non-O1 Vibrio cholerae. Lancet

(letter) 342:430

14. Hall, RH, FM Khambaty, M Kothary, SP Keasler, BD Tall (1994) Vibrio cholerae non-

O1 serogroup associated with cholera gravis genetically and physiologically resembles

O1 El Tor cholera strains. Infect Immun 62:3859-63

15. Sathyamoorthy, V, JS Huntley, AC Hall, RH Hall (1997) Biochemical and physiological

characteristics of HlyA, a pore-forming hemolysin of Vibrio cholerae serogroup O1.

Toxicon 35:515-27

16. Huntley, JS, V Sathyamoorthy, RH Hall, AC Hall (1997) Characteristics of the hemolytic

process induced by HlyA, a pore-forming toxin of Vibrio cholerae. Human & Exp. Toxicol

16:101-5

17. Ghosh, C, RK Nandy, SK Dasgupta, GB Nair, RH Hall, AC Ghose (1997) A search for

cholera toxin (CT), toxin coregulated pilus (TCP), the regulatory element ToxR and other

virulence factors in non-O1/non-O139 Vibrio cholerae. Microb Pathogen 22:199-208

18. Czeczulin, JR, S Balepur, S Hicks, A Phillips, RH Hall, MH Kothary, F Navarro-Garcia,

JP Nataro (1997) Aggregative Adherence Fimbria II, a second fimbrial antigen mediating

aggregative adherence in enteroaggregative Escherichia coli. Infect Immun 65:4135-45

19. Sengupta TK, RK Nandy, S Mukhopadhyay, RH Hall, V Sathyamoorthy, AC Ghose

(1998) Characterization of a 20-kDa pilus protein expressed by a diarrheogenic strain of

on-O1/non-O139 Vibrio cholerae. FEMS Microbiol Lett 160:183-9

20. McCardell, BA, MH Kothary, RH Hall, V. Sathyamoorthy. (2000). Identification of a

CHO cell-elongating factor produced by Vibrio cholerae O1. Microb. Pathog. 29:1-8

21. Sathyamoorthy, V, RH Hall, BA McCardell, MH Kothary, SJ Ahn, S Ratnayake (2000)

Purification and characterization of a cytotonic protein expressed in vitro by the live

cholera vaccine candidate CVD 103-HgR. Infect Immun 68:6062-5

22. Ge, B, C Larkin, S Ahn, M Jolley, M Nasir, J Meng, RH Hall (2002). Identification of

Escherichia coli O157:H7 and other enterohemorrhagic serotypes by strand

displacement amplification and fluorescence polarization. Molec & Cell Probes 16:85-92

23. Hall RH (2002) Biosensor Technologies for detecting microbiological foodborne

hazards. Microbes & Infection (4):425-32

24. Ge B, S Zhao, RH Hall, J Meng (2002) A PCR-ELISA for detecting Shiga toxin-

producing Escherichia coli. Microbes & Infection 3:285-90

25. Chakroborty, AK, RH Hall, AC Ghose (2002). Purification and characterization of a

potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell s

viper. Molec Cell Biochem 237:95-102

26. Walker, RI, LL Van De Verg, RH Hall, CK Schmitt, K Woo, V Hale (2005) Enteric

vaccines for pediatric use. A workshop summary. Vaccine 16;23(46-47):5432-9.

27. Hall RH (2011). A De in the Life of Cholera. Ind. J. Med. Res.133:146-152.

28. RH Hall, Peeling, R, D Burgess, J Farrar, Typhoid Diagnostics Working Group (2011)

Diagnostics for Enteric Fever: A Meeting Report. Manuscript in NIH review

International conference proceedings published as book chapters

1. Kaper, JB, MM Levine, DA Herrington, J Michalski, J Galen, RH Hall, J Ketley (1986)

Recent advances in developing a safe and effective live oral attenuated Vibrio cholerae vaccine.

In: Advances in research on cholera and related diarrheas. S. Kuwahara & N. Pierce, eds;6:

KTR Scientific Publ. Tokyo

2. Herrington, DA, G Losonsky, RH Hall, JJ Mekalanos, RK Taylor, MM Levine (1987)

Evaluation of toxR and tcpA mutant strains of Vibrio cholerae O1 in volunteers. In: Advances in

research on cholera and related diarrheas;7: S. Kuwahara & N. Pierce, eds. KTR Scientific

Publ. Tokyo

3. Levine, MM, JB Kaper, JG Morris, DA Herrington, G Losonsky, RH Hall (1988)

Reactogenicity, colonizing capacity, and immunogenicity of further attenuated, genetically -

engineered Vibrio cholerae O1 strains. In: Advances in research on cholera and related

diarrheas, 5:225-230. S. Kuwahara & N. Pierce, eds. KTR Scientific Publ. Tokyo

4. Hall, RH, J-G Xu (1994) Rapid identification of enterohemorrhagic Escherichia coli by

targeting unique hlyAB sequences. Proc. of the 30th US-Japan Joint Conference of Medical

Program Panel on Cholera & Related Diarrheas

5. Xu, J-G, Y-P Wu, B-K Cheng, L-B Huang, B-Y Liu, RH Hall (1996) Antisera to cell

surface protein and to the O157 antigen implicate a 67 KDa protein in the adherence of

Escherichia coli O157:H7 to HEp-2 cells. In: Cytokines, Cholera, & the Gut. Eds. G. T. Keusch &

M. Kawakami pp 329 - 336. IOS Press Amsterdam, Netherlands

6. Xu, J-G, Y-P Wu, Q-D Deng, H-F Xiao, RH Hall, X-H Lai, B-K Cheng, L-B Huang, B-Y

Liu (1996) Characterization of a Shiga-like toxin producing and invasive Escherichia coli strain:

a possible new variety of diarrheagenic pathogen. In: Cytokines, Cholera, & the Gut. Eds. G. T.

Keusch & M. Kawakami pp 321 - 328. IOS Press Amsterdam, Netherlands

7. Hall, RH, Peeling, J Farrar, D Burgess, & The Enteric Fever Diagnostics Consortium

(2011) Meeting the Challenge of Diagnosing Enteric Fever. Proc 46th US-Japan Joint Panel

Conference on Cholera and Other Bacterial Enteric Infections, Kolkata, India. In The Press

ABSTRACTS

1 Sutton, CW, RH Hall, DA Broadbent (l985) Purification and characterisation of

haemolysin from Vibrio cholerae biotype El Tor J Med Microbiol 20:iii

2 Young, DB, RH Hall, DA Broadbent (l985) Extracellular deoxyribonuclease enzymes

of Vibrio cholerae. J Med Microbiol 20:pXV

3 Hall, RH, CW Sutton, DB Young, DA Broadbent (l985) Effects of extracellular

products of Vibrio cholerae on cells in tissue culture. J Med Microbiol 20:pXV1

4 Hall, RH, AC Hall, C Ellory, CW Sutton, DA Broadbent (l985) The molecular mass of

Vibrio cholerae haemolysin measured by radiation inactivation analysis. Biochem Soc

Trans 3:1251-2

5 Hall, RH, AC Hall, C Ellory (1986) The effects of Vibrio cholerae haemolysin on cation

transport in human erythrocytes. Biochem Soc Trans 14:120-1

6 Hall, RH, JH Collins, R Patniak, MM Levine (1988) Purification and analysis of native

coli surface antigens 1 and 3 from enterotoxigenic Escherichia coli. ASM Miami, FL

7 Hall, RH, J Bansal, PA Vial. (1988) Preparation and application of monoclonal antibody

to Vibrio cholerae O1 TcpA pili. ASM Miami, FL

8 Hall, RH, B Drasar, K Yamamoto, JB Kaper (1989) Neutralization of cytotoxicity can

select hybridoma clones secreting anti-cytolysin antibody. ASM New Orleans, LA

9 Hall, RH, A Silveira, P Vial (1990) Expression, purification and analysis of toxin

co-regulated pili from classical Vibrio cholerae O1. ASM Anaheim, CA

10 Hall, RH, D Maneval (1990) Enterotoxigenic Escherichia coli surface antigens CS 3

and CS 6 each contain two distinct polypeptides. ASM Anaheim, CA

11 Hall, RH, GA Losonsky, APD Silveira, RK Taylor, JJ Mekalanos, ND Witham, MM

Levine (1991) Immunogenicity of Vibrio cholerae O1 toxin coregulated pili in

experimental and clinical cholera. ASM Dallas, TX

12 Keasler, SP, RH Hall (1992) Detection and classification of Vibrio cholerae O1 using

the polymerase chain reaction. FDA Science Expo '92, Rockville, MD

13 Keasler, SP, RH Hall (1992) Detection of Vibrio cholerae O1 using the polymerase

chain reaction. ASM New Orleans, LA

14 Foxall, PA, APD Silveira, RH Hall (1992) Cholera toxin B-subunit expression by ctxA-

Vibrio cholerae O1 deletion mutants. ASM New Orleans, LA

15 Hall, RH, FM Khambaty, M Kothary, SP Keasler, BD Tall (1993) Vibrio cholerae non-

O1 associated with cholera gravis genetically and physiologically resembles O1 El Tor

cholera strains. 29th Joint Conference on Cholera and Related Diarrheal Diseases, US -

Japan Cooperative Medical Sciences Program. Asilomar CA

16 Huntley, J, AC Hall, V Sathyamoorthy, RH Hall (1993) Thermostable direct hemolysin

(TDH) of Vibrio parahaemolyticus increases the cation permeability of erythrocyte

membranes. ASM Atlanta, GA

17 Miliotis, MD, BD Tall, RH Hall, CM Kondratick, RT Gray, KA Lampel, MH Kothary

(1993) Type 3 fimbriae of enterotoxigenic Klebsiella pneumoniae. ASM Atlanta, GA.

18 Miliotis, MD, BD Tall, RT Gray, RH Hall (1993) Adherence of enterotoxigenic

Klebsiella pneumoniae to HeLa cells and expression of type 3 fimbriae. Proc. 51st Ann.

Mtg. of the Microscopy Soc. of Amer. Cincinnati, OH

19 Nataro, JP, Y Deng, Y Deng, J Giron, S Savarino, RH Hall (1993) Aggregative

adherence fimbriae I expression in enteroaggregative Escherichia coli requires two

plasmid regions. ASM Atlanta, GA

20 Hall, RH, J-G Xu (1994) Rapid Identification of Enterohemorrhagic Escherichia coli by

Targeting Unique hlyAB Sequences. FDA Science Forum '94, Washington DC

21 Hall, RH, FM Khambaty, MH Kothary, SP Keasler, BD Tall (1994) Vibrio cholerae

non-O1 associated with cholera gravis genetically and physiologically resembles O1 El

Tor cholera strains. FDA Science Forum '94, Washington DC

22. Hall, R, GJ Doellgast, BA McCardell, V Sathyamoorthy, JM Madden (1997) Specific,

sensitive, and rapid detection of Staphylococcal enterotoxins A, B, C1, C2, C3, D and E

using an enzyme-linked coagulation-based immunosorbent assay. Proc. of the 33rd US-

Japan Joint Conference of Medical Program Panel on Cholera & Related Diarrheas

23. RH Hall, V Sathyamoorthy, B McCardell, M Kothary, S Ahn, S Ratnayake (1999)

Purification of a cytotonic agent from Vibrio cholerae. IXth International Congress of

Bacteriology & Applied Microbiology, International Union of Microbiological Societies,

August 16-20, 1999, Sydney, Australia

24 Ahn, S, B Ge, S Ratnayake, C Larkin, M Jolley, M Nasir, J Meng, RH Hall (2000)

Specific Detection of Enterohemorrhagic E. coli With PCR Amplification of an EHEC-

hlyA Sequence. ASM Los Angeles, CA

25 Ge, B, C Larkin, S Ahn, M Jolley, M Nasir, RH Hall, J Meng (2000) Identification of

Escherichia coli O157:H7 and other enterohemorrhagic serotypes by EHEC-hlyA

targeting, strand displacement amplification and fluorescent polarization readout. ASM,

Los Angeles, CA

26 Hall RH, D Misra, S Payne, T Hall, A Shifa, G Thoma (2011) 46 years of the US-Japan

Joint Panel on Cholera and Other Bacterial Enteric Infections: quantitative assessment

of a health sciences program. Proc 46th US-Japan Joint Panel Conference on Cholera

and Other Bacterial Enteric Infections, Kolkata, India

Contact this candidate